ADAMAX is a synthetic, modified analogue of Semax, an ACTH-derived heptapeptide. Its structure incorporates terminal modifications, including an adamantane-related group, and is studied in laboratory models involving peptide stability, neurotrophic signaling, and neuronal-response pathways.
Structure: Modified Semax-derived synthetic peptide
Parent Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
Modification: N-terminal acetylation and C-terminal adamantane-related modification
Molecular Formula: Formulation-dependent; verify against batch-specific analytical documentation
Research Focus: Peptide stability, neurotrophic signaling, and neuronal-response pathways
Research Use Only: Not intended for human or veterinary use.